Boule Diagnostics AB | Ownership

Companies that own Boule Diagnostics AB

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Svolder AB (Investment Management)
2,060,000
10.61%
0
6.87%
03/31/2018
Skandinaviska Enskilda Banken AB (Private Banking)
1,890,776
9.74%
234,432
37.85%
03/31/2018
Swedbank Robur Fonder AB
1,785,760
9.19%
0
0.03%
03/31/2018
Tredje AP-fonden
1,424,000
7.33%
0
0.12%
03/31/2018
Länsförsäkringar Fondförvaltning AB
709,424
3.65%
113,012
0.11%
03/31/2018
SEB Investment Management AB
622,744
3.21%
0
0.02%
12/31/2017
Humle Kapitalförvaltning AB
469,136
2.42%
-199,484
1.98%
12/31/2017
Andra AP-fonden
392,776
2.02%
392,776
0.03%
03/31/2018
Fondita Fund Management Co. Ltd.
372,728
1.92%
0
0.45%
07/31/2018
Norges Bank Investment Management
320,000
1.65%
320,000
0%
12/31/2017

About Boule Diagnostics AB

View Profile
Address
Domnarvsgatan 4
Spanga AB 163 53
Sweden
Employees -
Website http://www.boule.se
Updated 07/08/2019
Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. It offers automated blood cell counting systems for both the global human and veterinary market. The company was founded in 1992 and is headquartered in Spanga, Sweden.